REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Trate Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Merchant Wholesalers, Durable Goods | Information | Rental and Leasing Services | Scientific Research and Development Services | Advertising, Public Relations, and Related Services | Marketing Research and Public Opinion Polling | All Other Professional, Scientific, and Technical Services | Educational Services | Other Personal Care Services
Full name: Trate Sp. z o.o. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Trate AG operates in the field of dentistry and implantology, offering products, services, training courses, events, and customer surveys in this industry.

Headquarters
Ul. Bernardynska 16C/U1
Warsaw; Mazowieckie; Postal Code: 02-904

Contact Details: Purchase the Trate Sp. z o.o. report to view the information.

Website: http://www.trate.com

Basic Information
Total Employees:
Purchase the Trate Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Trate Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Trate Sp. z o.o. report to view the information.
Incorporation Date:
November 25, 2014
Key Executives
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Trate Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
9.79%▲
Total operating revenue
7.82%▲
Operating profit (EBIT)
54.17%▲
EBITDA
52.36%▲
Net Profit (Loss) for the Period
78.39%▲
Total assets
34.95%▲
Total equity
87.92%▲
Operating Profit Margin (ROS)
6.73%▲
Net Profit Margin
8.55%▲
Return on Equity (ROE)
-2.49%▼
Quick Ratio
0.13%▲
Cash Ratio
-0.02%▼

Similar companies

"Farmacol" S.A.
 
Gsk Services Sp. z o.o.
Super-Pharm Poland Sp. z o.o.
 
"Acs Audika Sp. z o.o."
Przedsiebiorstwo Zaopatrzenia Farmaceutycznego "Cefarm-Warszawa" S.A.
 
Sonova Audiological Care Polska Sp. z o.o.
Hager Polonia Sp. z o.o.
 
Gammamedica Sp. z o.o.
Akmed Andrzejewscy sp. j.
 
Gamine Sp. z o.o.
"Nz Techno" Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo